168 studies found for:    Ataxia
Show Display Options
RSS Create an RSS feed from your search for:
Ataxia
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias
Conditions: Spinocerebellar Ataxia Type 1;   Spinocerebellar Ataxia Type 2;   Spinocerebellar Ataxia Type 3;   Spinocerebellar Ataxia Type 6
Intervention: Genetic: All Participants
2 Not yet recruiting Functional and Structural Imaging and Motor Control in Spinocerebellar Ataxia
Condition: Spinocerebellar Ataxia
Interventions: Behavioral: Error-reduction;   Behavioral: International Cooperative Ataxia Rating Scale;   Behavioral: Scale for the Assessment and Rating of Ataxia
3 Active, not recruiting Preliminary Study of the Scale To Assess Ataxia and Neurologic Dysfunction (STAND)
Conditions: Spinocerebellar Ataxia - All Sub-types;   Friedreich's Ataxia
Intervention: Other: Ataxia rating scale
4 Active, not recruiting Biomarkers in Autosomal Dominant Cerebellar Ataxia
Conditions: Spinocerebellar Ataxia Type 1;   Spinocerebellar Ataxia Type 2;   Spinocerebellar Ataxia, Autosomal Recessive 3;   Episodic Ataxia, Type 7
Intervention: Other: metabolic and imaging biomarkers in SCA1,2,3 and 7 patients
5 Not yet recruiting Biomarkers in Friedreich's Ataxia
Condition: Friedreich's Ataxia
Intervention:
6 Enrolling by invitation 4-Aminopyridine in Episodic Ataxia Type 2
Condition: Episodic Ataxia Type 2
Interventions: Drug: 4-Aminopyridine;   Drug: Placebo
7 Completed Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar Ataxia
Conditions: Hereditary Ataxia;   Multiple Sclerosis;   Cerebellar Ataxia
Interventions: Drug: Riluzole;   Other: placebo
8 Completed Safety Study of Carbamylated Erythropoietin to Treat Patients With the Neurodegenerative Disorder Friedreich's Ataxia
Condition: Friedreich's Ataxia
Interventions: Drug: Lu AA24493;   Drug: Placebo
9 Completed
Has Results
Interferon Gamma-1b in Friedreich Ataxia (FRDA)
Condition: Friedreich Ataxia
Intervention: Drug: Interferon Gamma-1b
10 Completed Efficacy of Riluzole in Hereditary Cerebellar Ataxia
Condition: Cerebellar Ataxia
Interventions: Drug: riluzole;   Drug: Placebo comparator
11 Completed A Study of Resveratrol as Treatment for Friedreich Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Resveratrol
12 Recruiting Transcranial Magnetic Stimulation in Spino-Cerebellar Ataxia
Condition: Spinocerebellar Ataxia
Intervention: Device: Transcranial Magnetic Stimulation
13 Recruiting Early and Longitudinal Assessment of Neurodegeneration in the Brain and Spinal Cord in Friedreich's Ataxia
Condition: Friedreich Ataxia
Intervention:
14 Enrolling by invitation Susceptibility to Infections in Ataxia Telangiectasia
Conditions: Ataxia Telangiectasia;   Infections;   Immunodeficiency;   Lung Disease
Interventions: Procedure: Blood collection;   Procedure: Lung function measurement;   Behavioral: Symptom diary
15 Not yet recruiting Methylprednisolone Treatment of Friedreich Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Methylprednisolone
16 Recruiting Clinical Study to Evaluate the Safety and Efficacy BMMNC in Cerebellar Ataxia
Condition: Cerebellar Ataxia
Intervention: Biological: Intravenous transfer of of Bone Marrow derived Mono Nuclear Stem Cell (BMMNCs)
17 Completed
Has Results
Dalfampridine and Gait in Spinocerebellar Ataxias
Conditions: Spinocerebellar Ataxias Type 1;   Spinocerebellar Ataxias Type 2;   Spinocerebellar Ataxias Type 3;   Spinocerebellar Ataxias Type 6
Interventions: Drug: Dalfampridine;   Drug: Placebo
18 Completed Body Composition and Hormonal Status in Ataxia Telangiectasia
Condition: Ataxia Telangiectasia
Interventions: Procedure: bioelectrical impedance analysis;   Procedure: blood draw
19 Completed
Has Results
Study to Assess the Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia Patients
Condition: Friedreich's Ataxia
Intervention: Drug: Idebenone
20 Recruiting RTA 408 Capsules in Patients With Friedreich's Ataxia - MOXIe
Condition: Friedreich Ataxia
Interventions: Drug: RTA 408 Capsules, 2.5 mg;   Drug: RTA 408 Capsules, 5 mg;   Drug: RTA 408 Capsules, 10 mg;   Drug: Placebo;   Device: RTA 408 Capsules, 20 mg;   Drug: RTA 408 Capsules, TBD mg

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years